Indications and Purposes
| 1 Indications And Usage Kaletra Is Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Hiv-1 Infection In Adults And Pediatric Patients 14 Days And Older. Limitations Of Use: Genotypic Or Phenotypic Testing And/or Treatment History Should Guide The Use Of Kaletra. The Number Of Baseline Lopinavir Resistance-Associated Substitutions Affects The Virologic Response To Kaletra [see Microbiology ( 12.4 )] . Kaletra Is An Hiv-1 Protease Inhibitor Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Hiv-1 Infection In Adults And Pediatric Patients (14 Days And Older). ( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 2 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Lopinavir |
|
ZINC3951740 |
| 2. Ritonavir |
|
ZINC3944422 |